Back to SYRE

EMERALD ADVISERS, LLC → SYRE

EMERALD ADVISERS, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$50.8M
Q3 2026
Peak value
$50.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$20.8M
Q1 2026$30.9M
Q2 2026$50.4M
Q3 2026$50.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$50.8M571.0K——
Q2 2026$50.4M567.4K——
Q1 2026$30.9M613.4K——
Q4 2025$20.8M636.1K——

Other funds holding SYRE

Other EMERALD ADVISERS, LLC positions

TVTX

TRAVERE THERAPEUTICS INC

$92.1M
TVTX

TRAVERE THERAPEUTICS INC

$90.9M
GH

GUARDANT HEALTH INC

$88M
CORT

CORCEPT THERAPEUTICS INC

$87.4M
MOD

MODINE MANUFACTURING CO

$81.9M
CDNL

CARDINAL INFRASTRUCTURE GROUP

$79.9M
MRCY

MERCURY SYSTEMS INC

$78.1M
GH

GUARDANT HEALTH INC

$77.8M